Clinical Trials
2 trialsNCT00528281 2017-11-17
A Phase II Trial of Lapatinib (TYKERB) + Pemetrexed (ALIMTA) in Advanced Non Small Cell Lung Cancer With an Initial Dose Finding Phase
GlaxoSmithKline
Phase 1 Completed
NCT00073008 2017-02-28
A Study Of Oral GW572016 In Advanced Or Metastatic Non-Small Cell Lung Cancer
GlaxoSmithKline
Phase 2 Terminated